common.study.topics.clinical

Low Dose Fat-Induced Insulin Resistance

common.study.values.description

Low Dose Fat-Induced Insulin Resistance

The primary goal of this study is to determine the dose of fatty acids that acutely induces mild insulin resistance in healthy volunteers. We hypothesize that a low-dose of fatty acid infusion (Intralipid/heparin) will cause a mild insulin resistance. The dose of fatty acid infusion that reliably causes mild insulin resistance will be selected for use in future studies.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Intralipid, 20% Intravenous Emulsion

Fatty Acid Infusion, either in low-dose (30 ml/hr) or medium-dose (60 ml/hr)

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Dose Finding Study for Fat-Induced Insulin Resistance in Healthy Volunteers

common.study.values.clinical-trial-id

NCT03479671

participant.views.study.view.id

1aKP8b